{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:12:09Z","timestamp":1773731529349,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.fertnstert.2013.01.095","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T17:06:12Z","timestamp":1360083972000},"page":"1615-1622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments"],"prefix":"10.1016","volume":"99","clinical-trial-number":[{"clinical-trial-number":"nct01468441","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Luiz Guilherme Louzada","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Jos\u00e9 Gon\u00e7alves","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Souza","family":"Setti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Assumpto","family":"Iaconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Edson","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.01.095_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.fertnstert.2009.02.075","volume":"94","author":"Cavagna","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.fertnstert.2005.07.1318","article-title":"Administration of alternate day triptorelin for controlled ovarian hyperstimulation is cost effective","volume":"85","author":"Karatekeli","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","author":"Cheung","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.fertnstert.2010.06.068","article-title":"Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis","volume":"95","author":"Bodri","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/15.6.1211","article-title":"Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists","volume":"15","author":"Hernandez","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib8","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/humrep\/15.10.2145","article-title":"Addition of GnRH antagonist in cycles of poor responders undergoing IVF","volume":"15","author":"Akman","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.fertnstert.2008.04.064","article-title":"Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality","volume":"91","author":"Orvieto","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/humrep\/15.1.29","article-title":"Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation","volume":"15","author":"Out","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.fertnstert.2003.07.027","article-title":"Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in\u00a0vitro fertilization-embryo transfer patients","volume":"81","author":"Escudero","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1472-6483(10)61113-3","article-title":"GnRH antagonists in IVF","volume":"10","author":"Kolibianakis","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10815-006-9036-2","article-title":"Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol","volume":"23","author":"Koichi","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.fertnstert.2006.02.110","article-title":"Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in\u00a0vitro fertilization: a prospective, randomized trial","volume":"86","author":"Serafini","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/8.6.543","article-title":"The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction","volume":"8","author":"Filicori","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib17","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/deh415","article-title":"Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study","volume":"19","author":"Dal Prato","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib18","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.fertnstert.2008.02.165","article-title":"Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40","volume":"91","author":"Sbracia","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/humrep\/den468","article-title":"Improving the patient's experience of IVF\/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.fertnstert.2009.08.033","article-title":"Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in\u00a0vitro fertilization\u2013embryo transfer cycles","volume":"94","author":"Younis","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.fertnstert.2010.07.1073","article-title":"GnRH-agonist induced depressive and anxiety symptoms during in\u00a0vitro fertilization-embryo transfer cycles","volume":"95","author":"Bloch","year":"2011","journal-title":"Fertil Steril"},{"issue":"159 Suppl 1","key":"10.1016\/j.fertnstert.2013.01.095_bib22","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1530\/EJE-08-0354","article-title":"GnRH analogues: applications in assisted reproductive techniques","author":"Hayden","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2002-36713","article-title":"GnRH agonists, antagonists, and assisted conception","volume":"20","author":"van Loenen","year":"2002","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.fertnstert.2009.08.066","article-title":"Reasons for dropping out from a waiting list for in\u00a0vitro fertilization","volume":"94","author":"van Dongen","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.fertnstert.2009.07.990","article-title":"Determinants of patients' experiences and satisfaction with fertility care","volume":"94","author":"Mourad","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib27","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.fertnstert.2009.06.020","article-title":"A prospective investigation into the reasons why insured United States patients drop out of in\u00a0vitro fertilization treatment","volume":"94","author":"Domar","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1472-6483(10)60337-9","article-title":"Affordable IVF for developing countries","volume":"15","author":"Ombelet","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/15.2.314","article-title":"In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic","volume":"15","author":"Janssens","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib30","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1093\/humrep\/dep253","article-title":"Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study","volume":"24","author":"Blockeel","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.fertnstert.2005.02.036","article-title":"Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation","volume":"84","author":"Filicori","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2004.10.032","article-title":"Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in\u00a0vitro fertilization","volume":"83","author":"Fabregues","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0015-0282(16)60437-5","article-title":"Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in\u00a0vitro fertilization and their consequences for embryo development","volume":"51","author":"Loumaye","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2013.01.095_bib35","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1093\/oxfordjournals.humrep.a135742","article-title":"The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques","volume":"10","author":"Tarlatzis","year":"1995","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213001386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213001386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:05:36Z","timestamp":1758009936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0015028213001386"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.01.095","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.01.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}